Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of MBA-P01 (Newlux) vs Botox for Glabellar Lines
NCT05059587Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluorometholone acetate in glabellar lines, sponsored by Medytox Inc.. Started Aug 2021; status: completed.
02
Drugs
fluorometholone acetate
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05059587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059587.